Life Sciences

Who’s Who Legal: Life Sciences 2024
Three Carpmaels partners recognised as leaders in life sciences patent litigation
Read More
25
Apr
2024
Carpmaels in Conversation: Ep.32 – Can trade secrets help innovation in healthcare?
Episode overview
Read More
03
Apr
2024
Creativity from complexity: patentability opportunities for multispecific antibodies
Multispecific antibodies can face many of the same patentability objections as monospecific antibodies, but their greater structural complexity gives applicants more options in argument and amendment
Read More
13
Mar
2024
Decision making at the UPC: Life sciences, Robotics, and MedTech
Sector-specific factors to consider when deciding on a strategy for using the UPC system
Read More
07
Dec
2023
Enlarged Board of Appeal delivers decisions on formal priority entitlement
The EPO Enlarged Board of Appeal has held that the applicant benefits from a rebuttable presumption under the EPC that the applicant claiming priority is entitled to claim priority
Read More
10
Oct
2023
Decision making at the UPC: Life sciences sector
Companies in the life sciences sector show a healthy appetite to engage with the new court system as the Unified Patent Court opens its doors and Unitary Patents begin to grant – is it time for more companies to join them?
Read More
06
Oct
2023
Legal 500 2024
Carpmaels retains Tier 1 ranking
Read More
04
Oct
2023
Managing IP Rankings 2023
Carpmaels ranked tier 1 for patent disputes and patent prosecution
Read More
22
Sep
2023
Carpmaels engages with EPO consultation on Rules of Procedure of Boards of Appeal
The EPO is proposing revisions to the Rules of Procedure of the Boards of Appeal, but the changes could place undue time pressure on parties
Read More
19
Sep
2023
Potential referral to the EPO Enlarged Board on description amendments
Clarity at last? An EPO Board of Appeal has suggested a referral on the issue of description amendments
Read More
25
Jul
2023

Type

Service

Sector

Archive